These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 6975509

  • 1. The PFD test for pancreatic disease patients.
    Miwa M, Kikuchi K, Senoue I, Watanabe H, Nomiyama T, Suzuki S, Harasawa S, Tani N, Miwa T, Sugita T.
    Tokai J Exp Clin Med; 1981 Jul; 6(3):309-13. PubMed ID: 6975509
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The exocrine pancreatic function (PABA) test and its clinical applications].
    Zhou ZC, Zhang XQ, Chen MZ, Lu XH, Lu GJ, Bi ZH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Dec; 4(6):352-7. PubMed ID: 6221814
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The NBT-PABA test in the diagnosis of exocrine pancreatic insufficiency (author's transl)].
    Lankisch PG, Ehrhardt-Schmelzer S, Koop H, Caspary WF.
    Dtsch Med Wochenschr; 1980 Oct 10; 105(41):1418-23. PubMed ID: 6969654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Functional examination of the pancreas with indirect methods (the NBT-PABA test and pancreolauryl test) in patients with chronic pancreatic diseases].
    Martínez Martínez LM, González Villarón L, Sánchez Sánchez R, Rodrigo Sáez L, de Castro del Pozo S.
    Rev Clin Esp; 1985 Oct 10; 177(6):258-62. PubMed ID: 3878546
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical study of exocrine pancreatic function test by oral administration by N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Kimura T, Wakasugi H, Ibayashi H.
    Digestion; 1981 Oct 10; 21(3):133-9. PubMed ID: 7011889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. B.T.PABA test: a new absorption test.
    Miwa M, Senoue I, Watanabe H, Nomiyama T, Sakita R, Suzuki S, Harasawa S, Tani N, Miwa T.
    Tokai J Exp Clin Med; 1980 Jan 10; 5(1):1-13. PubMed ID: 6966841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral administration of chymotrypsin labile peptide for a new test of exocrine pancreatic function (PET) in comparison and pancreozymin-secretin test.
    Imamura K, Nakamura T, Miyazawa T, Abe Y, Kobayashi M, Takebe K, Toyota T.
    Am J Gastroenterol; 1978 May 10; 69(5):572-8. PubMed ID: 308313
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [PABA test versus chymotrypsin and fat determinations in the stool in pancreatic functional diagnosis].
    Bühler H, Ammann R.
    Schweiz Med Wochenschr; 1979 Apr 21; 109(16):597-8. PubMed ID: 311946
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.